NURS 684 Exam2 with Questions Solved 100%
Correct | Verified Answers
T/F? Data supports the use of hormonal therapy for prevention of cognitive decline if started
soon after menopause. - ✔✔FALSE
While some studies indicate that starting hormone therapy early post-menopause may have a
positive impact on cognitive function, the research is not definitive and other studies have
shown no significant benefit or even increased risk of dementia in older postmenopausal
women taking hormone therapy.
An advantage of the transdermal patch over oral delivery of estrogen for women experiencing
menopausal symptoms is that the transdermal delivery method_____________________. -
✔✔Has less adverse effects on coagulation factors!
- avoids first-pass medication, so it can be given in lower doses
- reduced risk of blood clots (oral estrogen increases risk of developing blood clots)
- reduced risk of stroke
- reduced impact on triglycerides, coagulation factors, and gallbladder disease
In one to two years postmenopausal women, you would expect the following hormone level
changes when compared with premenopausal women. - ✔✔Increased FSH, decreased ani-
mullerian hormone, decreased estradiol
Additionally, LH and FHS remain increased due to lack of feedback from the ovaries. Levels of
progesterone, estrogen (particularly estradiol) are all lower.
**estrodiol is a type of estrogen
, The woman who is going to take ospemifene (an estrogen agonist/antagonist) for treatment of
dyspareunia (painful intercourse) related to vulvovaginal atrophy should be advised that
she______________________ - ✔✔May experience hot flashes as a side effect of this
medication
Remember, the purpose of an estrogen antagonist is to block the action of estrogen. In doing
so, it can precipitate symptoms of menopause (like hot flashes).
Additionally, Ospemifene is a selective estrogen receptor modulator (SERM) used to treat
vaginal dryness and painful intercourse in postmenopausal women.
The number 1 cause of death in US women aged 65 and older is_______________________ -
✔✔Heart disease
Which of the following non-hormonal medications is FDA approved for treatment of vasomotor
symptoms? - ✔✔Paroxetine
Vasomotor symptoms are a form of temperature dysfunction that occurs due to changes in
hormones.
Paroxetine a (selective serotonin reuptake inhibitor (SSRI)) is the only nonhormonal treatment
that has been approved in the United States for moderate to severe vasomotor symptoms
associated with menopause. It works by reducing core body temperature and blood flow to the
skin.
A menopausal woman asks what complementary or alternative opinions to hormone therapy
might help with her hot flashes. Correct information would include would
be_____________________ - ✔✔Some herbal preparations can interfere with medications
A 70-year-old woman at the clinic for a well-woman visit in November has the following
immunization hx; 2 doses herpes zoster vaccine, 1PCV13 (pneumococcal conjugate vaccine),
Tdap booster. She has not had any vaccinations in the last 5 years. At this visit the
Correct | Verified Answers
T/F? Data supports the use of hormonal therapy for prevention of cognitive decline if started
soon after menopause. - ✔✔FALSE
While some studies indicate that starting hormone therapy early post-menopause may have a
positive impact on cognitive function, the research is not definitive and other studies have
shown no significant benefit or even increased risk of dementia in older postmenopausal
women taking hormone therapy.
An advantage of the transdermal patch over oral delivery of estrogen for women experiencing
menopausal symptoms is that the transdermal delivery method_____________________. -
✔✔Has less adverse effects on coagulation factors!
- avoids first-pass medication, so it can be given in lower doses
- reduced risk of blood clots (oral estrogen increases risk of developing blood clots)
- reduced risk of stroke
- reduced impact on triglycerides, coagulation factors, and gallbladder disease
In one to two years postmenopausal women, you would expect the following hormone level
changes when compared with premenopausal women. - ✔✔Increased FSH, decreased ani-
mullerian hormone, decreased estradiol
Additionally, LH and FHS remain increased due to lack of feedback from the ovaries. Levels of
progesterone, estrogen (particularly estradiol) are all lower.
**estrodiol is a type of estrogen
, The woman who is going to take ospemifene (an estrogen agonist/antagonist) for treatment of
dyspareunia (painful intercourse) related to vulvovaginal atrophy should be advised that
she______________________ - ✔✔May experience hot flashes as a side effect of this
medication
Remember, the purpose of an estrogen antagonist is to block the action of estrogen. In doing
so, it can precipitate symptoms of menopause (like hot flashes).
Additionally, Ospemifene is a selective estrogen receptor modulator (SERM) used to treat
vaginal dryness and painful intercourse in postmenopausal women.
The number 1 cause of death in US women aged 65 and older is_______________________ -
✔✔Heart disease
Which of the following non-hormonal medications is FDA approved for treatment of vasomotor
symptoms? - ✔✔Paroxetine
Vasomotor symptoms are a form of temperature dysfunction that occurs due to changes in
hormones.
Paroxetine a (selective serotonin reuptake inhibitor (SSRI)) is the only nonhormonal treatment
that has been approved in the United States for moderate to severe vasomotor symptoms
associated with menopause. It works by reducing core body temperature and blood flow to the
skin.
A menopausal woman asks what complementary or alternative opinions to hormone therapy
might help with her hot flashes. Correct information would include would
be_____________________ - ✔✔Some herbal preparations can interfere with medications
A 70-year-old woman at the clinic for a well-woman visit in November has the following
immunization hx; 2 doses herpes zoster vaccine, 1PCV13 (pneumococcal conjugate vaccine),
Tdap booster. She has not had any vaccinations in the last 5 years. At this visit the
